| 2D | Two-dimensional |
| ADPKD | Autosomal dominant polycystic kidney disease |
| AFM | Atomic force microscopy |
| AP | Action potential |
| APD | Action potential duration |
| ATM | Atomic force microscopy |
| AV Node | Atrioventricular node |
| HCM | Hypertrophic cardiomyopathy |
| Ca2+ | Calcium |
| CiPA | Comprehensive in vitro proarrhythmia assay |
| CM | Cardiomyocytes |
| CPVT | Catecholaminergic polymorphic ventricular tachycardia |
| CSAHI | Consortium for Safety Assessment using Human iPS cells |
| CVD | Cardiovascular disease |
| DCM | Familial dilated cardiomyopathy |
| FP | Field potential |
| FPDc | Field potential duration (corrected) |
| FRET | Fluorescence resonance energy transfer |
| GL-3 | Basic helix-loop-helix proteins, GLABRA3 |
| gpAPD | Guinea pig papillary muscle action potential assay |
| hERG | Human ether-a-go-go Related gene-voltage sensitive potassium channel |
| hiPSC | Human induced pluripotent stem cell |
| K+ | Potassium |
| LIMP-2 | Lysosomal integral membrane protein 2 |
| LMNA | Lamin A/C |
| MEA | Multi-/micro-electrode array |
| MYH7 | Myosin heavy chain 7 |
| Na+ | Sodium |
| PKD1/2 | Polycystic kidney disease 1 |
| RNA | Ribonucleic acid |
| SCN5A | Sodium voltage-gated channel alpha subunit 5 |
| TBX5 | T-box transcription factor |
| TdP | Torsade-de-Pointes-Tachycardia |
| TnnT | TroponinT |
| VSO | Voltage-sensitive optical system |
| WT | Wild type |